Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM. Dreyling, Marco Ladetto, Elı́as Campo et al.|Annals of Oncology|2017Cited by 736
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upM. Dreyling, Mats Jerkeman, Michele Ghielmini et al.|Annals of Oncology|2020Cited by 267
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Eva Hoster, Tom van Meerten et al.|The Lancet|2024Cited by 135
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAndrés J.M. Ferreri, M. Dreyling, Gerald Illerhaus et al.|Annals of Oncology|2024Cited by 46
Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐upAndrés J. M. Ferreri, Martin Dreyling, Gerald Illerhaus et al.|HemaSphere|2024Cited by 26